SERMS Tamoxifen Citrate Anti Estrogen Steroids White Powder 54965-24-1
Tamoxifen Citrate(Nolvadex) Specyfikacja:
Tamoxifen Citrate Name | Tamoxifen Citrate |
Tamoxifen Citrate CAS No. | 54965-24-1 |
Tamoxifen Citrate M F | C32H37NO8 |
Tamoxifen Citrate M W | 563.64 |
Tamoxifen Citrate EINECS | 259-415-2 |
Tamoxifen Citrate Purity | 99.51% |
Tamoxifen Citrate Appearance | Biały, krystaliczny proszek |
Tamoxifen Citrate Standard | Usp 30 |
Tamoxifen Citrate M P | 140-144 ° C |
Tamoxifen Citrate(Nolvadex) Przegląd:
Tamoxifen Citrate is an estrogen agonist in the liver, capable activating the estrogen receptor and mimicking the actions of this sex hormone in this region of the body. As the reason it can have a markedly positive impact on HDL cholesterol values also estrogen.
Tamoxifen Citrate is a selective estrogen blocker, also a non-steroidal agent that demonstrates potent anti-estrogenic properties. Tamoxifen Citrate is technically an estrogen agonist antagonist, which competitively binds to estrogen receptors in various target tissues. Since many forms of breast cancer are responsive to estrogen, the ability of which to block its action in such cells has proven to be a very effective treatment. It is also utilized successfully as a preventative measure, taken by people with an extremely high familial tendency for breast cancer.
Tamoxifen citrate (tamoxifen citrat e, referred to as TCT), is an estrogen (estrogenów) competitive antagonist, non-steroidal anti-estrogen drugs in the body with estrogen (female two Alcohol) competition, and breast cancer cells combined with estrogen receptor, thereby inhibiting the role of estrogen on cancer cells, so that tumor cell growth and development blocked, and play anti-cancer effect. Clinically used in the treatment of various types of breast cancer, especially for estrogen receptor and progesterone receptor-positive and prostate-specific antigen levels in postmenopausal women with lower breast cancer.
Tamoxifen Citrate(Nolvadex) Aplikacji:
1 . Tamoxifen Citrate is a Selective Estrogen Receptor Modulator (SERM),When gyno prone anabolic steroid users run aromatising compounds,Nolvadex can prevent some estrogen-related side effects from occurring, and it can halt the growth of gynecomastia.
2 . Nolvadex as such has no direct anabolic or androgenic effects. All its effects are secondary to the blockage of estrogen receptors. Nolvadex is known to block estrogen receptors in the body. When it blocks the estrogen receptors on the hypothalamus, the brain senses that the body is lacking in this sex hormone.
3 . Tamoxifen Citrate has a 6 day half-life, but in different medical documents it’s shown between 5 i 7 dni.
4 . For PCT use, Nolvadex is usually dosed at 40mg a day for a few weeks, then reduced to 20mg a day for the succeeding weeks and at 10mg a day for the last week. The end of your cycle is determined when you start your Nolva therapy.
Tamoxifen Citrate(Nolvadex) Coa
Nazwa produktu | Tamoxifen citrate (Nolvadex) |
Wygląd | Biały, krystaliczny proszek |
Identyfikacja | Ir , UV conform | Są zgodne |
Straty podczas suszenia | ≤0.5ml | 0.29ml |
Pozostałość przy zapłonie | Not more than 0.2% | 0.07ml |
Iron | Not more than 0.005% | 0.0027% |
Heavy metals | Not more than 0.001% | 0.0006% |
Substancje pokrewne | Total: Not more than 1.0% Individual: Not more than 0.5% | 0.36% 0.19% |
E-isomer | Not more than 0.3% | 0.12% |
Organic volatile impurities | Spełnia | Spełnia |
Badania | 97.5.0~102,0% | 99.2% |